Dimopoulos M, Tedeschi A, Trotman J, et al. Multinational, randomized phase 3 trial of ibrutinib-rituximab vs placebo-rituximab with Waldenström’s macroglobulinemia. EHA 2018, abstract S852.
KWF-subsidie voor betere therapie cutaan T-cellymfoom
jan 2023 | Dermato-oncologie, Lymfoom